Učitavanje...
Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison
BACKGROUND: Recent meta-analyses have found a survival advantage with gemcitabine based combinations over single agent gemcitabine in patients with advanced pancreatic cancer. There is paucity of evidence in the form of direct head-to-head randomised controlled trials to determine which combinations...
Spremljeno u:
| Glavni autori: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2008
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2474853/ https://ncbi.nlm.nih.gov/pubmed/18611273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-8-192 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|